Expert Opinion on Drug Discovery (1746-0441; 1746-045X) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug discovery.

Expert Opinion on Drug Discovery publishes original research and review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimization at the preclinical level.

Articles focus on the following key areas:

    Chemoinformatics
    Bioinformatics
    Assay development
    Novel screening technologies
    In vitro/in vivo models
    Structure-based drug design
    Systems biology


The journal also publishes drug case histories examining the steps involved in the preclinical and clinical development of a particular drug.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Drug Discovery, part of the Expert Collection brand.